Neuropsychiatric Symptom Management in Dementia Care

Neuropsychiatric symptom management in dementia care encompasses the systematic identification, monitoring and intervention for behavioural and psychological disturbances that accompany cognitive decline. These symptoms—ranging from agitation, psychosis and sleep disruption to depression, anxiety and apathy—profoundly affect patient quality of life and amplify caregiver burden. Evidence supports a combined approach: pharmacological treatments such as cholinesterase inhibitors and cautious use of antipsychotics may stabilise certain symptom domains, while non-pharmacological strategies—including environmental modifications, structured activities, sensory therapies and caregiver training—are first-line for most presentations. Recent innovations in remote and in-home assessment tools allow real-time tracking of symptom trajectories, enabling personalised adjustment of interventions. Moreover, network-based analytic frameworks have revealed central symptom nodes whose targeted modulation can yield broad improvements across behavioural clusters. The global imperative is to translate these advances into culturally appropriate, resource-sensitive care pathways that optimise patient autonomy, reduce institutionalisation rates and support sustainable caregiver involvement.

Research from Nature Portfolio

Recent observational research using a three-year home‐based cohort has illuminated dynamic links between behavioural symptoms and daily living activities in people with dementia. Quarterly assessments combining standardised functional scales and psychiatric inventories uncovered three severity-defined clusters, each associated with distinct patterns of caregiver anxiety and health-service engagement. Those with mild cognitive decline exhibited heightened caregiver distress, whereas individuals in the most severe cluster relied more on community services but had fewer hospital admissions. These findings underscore the importance of continuous, multidimensional monitoring to inform the timing and intensity of both psychosocial and pharmacological interventions, paving the way for adaptive care models that respond to evolving needs.

Neuropsychiatric Symptom Management in Dementia Care publication trend

The graph below shows the total number of articles in neuropsychiatric symptom management in dementia care across all publications each year (not limited to Nature Index journals).

Technical terms

Neuropsychiatric Inventory (NPI): A clinician-administered instrument for quantifying the frequency and severity of behavioural and psychological symptoms in dementia.

Behavioural and Psychological Symptoms of Dementia (BPSD): A collective term for non-cognitive disturbances such as agitation, depression, psychosis and apathy commonly seen in dementia.

Network analysis: A statistical approach that maps relationships among symptoms to identify central features for targeted intervention.

Activities of Daily Living (ADL): Standardised measures of basic and instrumental tasks essential for independent living.

Non-pharmacological interventions: Therapeutic strategies excluding medication, encompassing environmental adaptations, behavioural therapies and caregiver education.

References

1. Network analysis of neuropsychiatric symptoms in Alzheimer’s disease. Alzheimer's Research & Therapy (2023).
2. Longitudinal study of care needs and behavioural changes in people living with dementia using in-home assessment data. Communications Medicine (2025).
3. Sex differences in neuropsychiatric symptoms in Alzheimer’s disease dementia: a meta-analysis. Alzheimer's Research & Therapy (2022).
4. Neuropsychiatric or Behavioral and Psychological Symptoms of Dementia (BPSD): Focus on Prevalence and Natural History in Alzheimer's Disease and Frontotemporal Dementia. Frontiers in Neurology (2022).
5. The Hyperactivity–Impulsivity–Irritiability–Disinhibition–Aggression–Agitation Domain in Alzheimer’s Disease: Current Management and Future Directions. Frontiers in Pharmacology (2019).